| Title |
Genes located in Y-chromosomal regions important for male fertility show altered transcript levels in cryptorchidism and respond to curative hormone treatment / |
| Authors |
Gegenschatz-Schmid, Katharina ; Verkauskas, Gilvydas ; Stadler, Michael B ; Hadziselimovic, Faruk |
| DOI |
10.1186/s12610-019-0089-3 |
| Full Text |
|
| Is Part of |
Basic and clinical andrology.. London : BioMed Central Ltd.. 2019, vol. 29, art. no. 8, p. [1-8].. eISSN 2051-4190 |
| Keywords [eng] |
Ad spermatogonia ; AZF region ; Cryptorchidism ; GnRHa treatment ; Infertility ; LH ; Mini-puberty ; RNA-sequencing ; Testosterone ; Y-chromosome |
| Abstract [eng] |
Background: Undescended (cryptorchid) testes in patients with defective mini-puberty and low testosterone levels contain gonocytes that fail to differentiate normally, which impairs the development of Ad spermatogonia and ultimately leads to adult infertility. Treatment with the gonadotropin-releasing hormone agonist GnRHa increases luteinizing hormone and testosterone and rescues fertility in the majority of pathological cryptorchid testes. Several Y-chromosomal genes in the male-specific Y region (MSY) are essential for spermatogenesis, testis development and function, and are associated with azoospermia, infertility and cryptorchidism. In this study, we analyzed the expression of MSY genes in testes with Ad spermatogonia (low infertility risk patients) as compared to testes lacking Ad spermatogonia (high infertility risk) before and after curative GnRHa treatment, and in correlation to their location on the Y-chromosome. Results: Twenty genes that are up- or down-regulated in the Ad- group are in the X-degenerate or the ampliconic region, respectively. GnRHa treatment increases mRNA levels of 14 genes in the ampliconic region and decreases mRNA levels of 10 genes in the X-degenerate region. Conclusion: Our findings implicate Y-chromosomal genes, including USP9Y, UTY, TXLNGY, RBMY1B, RBMY1E, RBMY1J and TSPY4, some of which are known to be important for spermatogenesis, in the curative hormonal treatment of cryptorchidism-induced infertility. |
| Published |
London : BioMed Central Ltd |
| Type |
Journal article |
| Language |
English |
| Publication date |
2019 |
| CC license |
|
